Strategic Scale Qiming Venture Partners manages a broad portfolio across US Dollar and RMB funds with substantial capital raised and a proven track record of backing over 580 companies, indicating strong demand for scale-up capital and cross-border collaboration opportunities.

Portfolio Momentum A large portion of holdings have achieved exits or unicorn status, signaling potential for follow-on investments, secondary sales, and strategic partnerships with mature portfolio companies seeking growth capital, acquisitions, or global expansion.

Industry Focus Concentrations in Technology and Healthcare, combined with notable exits in consumer tech and biotech, suggest sales opportunities around AI, medical devices, digital health platforms, and biotech tools that align with Qiming’s investment theses.

Strategic Partnerships Active participation in notable rounds (for example Windward Bio, Pulnovo Medical, Stepfun) and collaborations with major strategics indicate openness to co-investments, strategic partnerships, and technology licensing or distribution deals with portfolio and adjacent companies.

Global Outreach With eleven US dollar funds and seven RMB funds and a global investor base, there is potential for international collaboration, cross-border product integrations, and market-entry services for portfolio companies expanding into Asia, North America, and Europe.